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Bacterial resistance to conventional antibiotics has become a clinical and public
health problem, making therapeutic decisions more challenging. Plant compounds and
nanodrugs have been proposed as potential antimicrobial alternatives. Studies have
shown that oregano (Origanum vulgare) essential oil (OEO) and silver nanoparticles
have potent antibacterial activity, also against multidrug-resistant strains; however, the
strong organoleptic characteristics of OEO and the development of resistance to these
metal nanoparticles can limit their use. This study evaluated the antibacterial effect
of a two-drug combination of biologically synthesized silver nanoparticles (bio-AgNP),
produced by Fusarium oxysporum, and OEO against Gram-positive and Gram-negative
bacteria, including multidrug-resistant strains. OEO and bio-AgNP showed bactericidal
effects against all 17 strains tested, with minimal inhibitory concentrations (MIC) ranging
from 0.298 to 1.193 mg/mL and 62.5 to 250 µM, respectively. Time-kill curves indicated
that OEO acted rapidly (within 10 min), while the metallic nanoparticles took 4 h to
kill Gram-negative bacteria and 24 h to kill Gram-positive bacteria. The combination
of the two compounds resulted in a synergistic or additive effect, reducing their
MIC values and reducing the time of action compared to bio-AgNP used alone, i.e.,
20 min for Gram-negative bacteria and 7 h for Gram-positive bacteria. Scanning
electron microscopy (SEM) revealed similar morphological alterations in Staphylococcus
aureus (non-methicillin-resistant S. aureus, non-MRSA) cells exposed to three different
treatments (OEO, bio-AgNP and combination of the two), which appeared cell surface
blebbing. Individual and combined treatments showed reduction in cell density and
decrease in exopolysaccharide matrix compared to untreated bacterial cells. It indicated
that this composition have an antimicrobial activity against S. aureus by disrupting cells.
Both compounds showed very low hemolytic activity, especially at MIC levels. This study
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describes for the first time the synergistic and additive interaction between OEO
and bio-AgNP produced by F. oxysporum against multidrug-resistant bacteria, such
as MRSA, and β-lactamase- and carbapenemase-producing Escherichia coli and
Acinetobacter baumannii strains. These results indicated that this combination can be
an alternative in the control of infections with few or no treatment options.
Keywords: oregano oil, biological silver nanoparticles, multidrug-resistant bacteria, synergism, antibacterial
INTRODUCTION
Bacterial antimicrobial resistance to most conventional
antibiotics has become a clinical and public health problem.
Infections due to multidrug-resistant microorganisms, such as
bacteria that produce extended-spectrum β-lactamases (ESBL)
and carbapenemases (Klebsiella pneumoniae carbapenemase,
KPC) and MRSA can be challenging to control leading to
high treatment costs, therapeutic failure and death (Silva and
Lincopan, 2012; Cantas et al., 2013).
ESBL and KPC hydrolyze the β-lactam ring resulting in
an inactive antimicrobial (Queenan and Bush, 2007; Drawz
and Bonomo, 2010). ESBLs mediate resistance to most β-
lactams, mainly in Gram-negative bacteria (Dhillon and Clark,
2012; Silva and Lincopan, 2012). In these cases, carbapenem
antibiotics, such as imipenem, meropenem, and ertapenem,
are drugs of choice for treatment. However, carbapenemases
reduce treatment options because they inactivate penicillins,
cephalosporins, monobactams, and carbapenems (Queenan and
Bush, 2007).
Usually ESBLs and KPC are encoded by genes carried by
mobile genetic elements which also carry resistance genes to
other antimicrobial agents, contributing to the emergence of
multidrug resistance and its rapid spread between different
strains and species (Pitout, 2012; Silva and Lincopan, 2012;
Patel and Bonomo, 2013; Shaikh et al., 2015). ESBL- and
KPC-producing strains usually exhibit resistance to quinolones,
tetracyclines, cotrimoxazol, trimethoprim, and aminoglycosides
(Dhillon and Clark, 2012; Pitout, 2012; Patel and Bonomo, 2013).
In Gram-positive bacteria, the most common mechanism
of resistance to β-lactam occurs due a mutant transpeptidase
gene. Methicillin resistance in S. aureus occurs because of the
mecA gene, which encodes transpeptidases that have low affinity
for β-lactam antibiotics (Rice, 2012). MRSA strains can harbor
resistance genes for other antimicrobials besides mecA, reducing
treatment options (Turlej et al., 2011).
Multiresistant bacteria have been found in foods for human
consumption, streams and effluents and thus it is a hospital,
community, and environmental problem (Prado et al., 2007;
Fontes et al., 2011; Silva and Lincopan, 2012; Rubin et al.,
2014; Koga et al., 2015). As soon as new β-lactams are
widely used, new β-lactamases are also discovered (Bush, 2010;
Kong et al., 2010; Shaikh et al., 2015). Therefore, there is
crucial need for research and development of new drugs
Abbreviations: OEO, oregano essential. oil; bio-AgNP, biological synthesized
silver nanoparticle; RBC, red blood cells.
with potential to combat resistant strains to minimize their
selection.
Compounds from natural sources such as animals, plants, and
microorganisms have been proposed as potential antimicrobial
alternatives (Mandal and Mandal, 2011; Cardozo et al., 2013;
Biasi-Garbin et al., 2015). Spice essential oils have been
documented as being antimicrobial (Burt, 2004; Du et al., 2009;
Betancourt et al., 2012; Nazzaro et al., 2013). Oil phenolic
substances are mainly responsible for antibiotic properties
(Rhayour et al., 2003; Burt, 2004; Nostro et al., 2007; Hyldgaard
et al., 2012).
Studies on the antibacterial mechanisms of action of plant
essential oils, including the OEO, suggest that hydrophobic
bioactive compounds cause damage to cell membrane, increase
cell permeability, affect ATP production, act on protein synthesis,
cause cellular pH disturbance, induce cytoplasmic changes and
interfere with quorum sensing (Helander et al., 1998; Ultee et al.,
1999; Lambert et al., 2001; Rhayour et al., 2003; Souza et al., 2010,
2013; Szabó et al., 2010; Hyldgaard et al., 2012).
OEO, extracted mainly from the leaves of the herb O. vulgare
by ecofriendly methods, has been reported as having broad
antibacterial activity (Burt, 2004; Busatta et al., 2007; Betancourt
et al., 2012). Other biological activities such as antifungal,
antiviral, antioxidant and anticancer have been described for
OEO (Cervato et al., 2000; Kalemba and Kunicka, 2003;
Hyldgaard et al., 2012; Gautam et al., 2014; Gilling et al., 2014;
Sobral et al., 2014).
Carvacrol and thymol are the main components of OEO
(Nostro et al., 2004; Cleff et al., 2008; Hyldgaard et al.,
2012; Stojkovic´ et al., 2013), and the antimicrobial activity
of this oil varies according to their amounts. Synergistic and
additive interactions between carvacrol and thymol have been
reported (Bassolé and Juliani, 2012; Hyldgaard et al., 2012);
furthermore, a mixture of compounds with antimicrobial activity
could minimize the selection of resistant strains. Studies have
shown that OEO has the potential to prevent food from being
contaminated and control worrisome hospital infections (Nostro
et al., 2004; Si et al., 2008; Barros et al., 2009; Amrouni et al.,
2014; Honório et al., 2015). Despite the potential antimicrobial
activity of OEO, its strong taste and smell seem to limit its use, so
alternatives are needed tominimize or eliminate such undesirable
characteristics (Burt, 2004; Alvarez et al., 2014).
Silver has been used for millennia to treat wounds and eye
infections and to preserve food and water (Alexander, 2009).
Nanotechnology has proved to be a useful tool for solving
biomedical problems. Silver nanoparticles have been intensively
studied as antimicrobial agents, including their use against
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multidrug-resistant bacteria (Li et al., 2010; Cardozo et al.,
2013; Naqvi et al., 2013; Ansari et al., 2014; Bibbs et al., 2014;
Palanisamy et al., 2014; Singh et al., 2014; Subashini et al.,
2014; Theophel et al., 2014). Through nanotechnology, it has
been possible to revive the use of silver to combat resistant
bacteria. Nanoscale enhances the antibacterial activity of silver
even at low concentrations; nanometer metallic particles show
altered physical, chemical and biological properties compared
to conventional silver, due to their high surface-to-volume ratio
(Nowack et al., 2011; Rai et al., 2012; Herman andHerman, 2014).
Furthermore, silver nanoparticles have been reported to be less
toxic than silver ions to host (de Lima et al., 2012).
The bactericidal mechanism of silver nanoparticles is not
clearly understood; however, it is believed that there is a multiple
mechanism of action (Herman and Herman, 2014). Researchers
have suggested that silver nanoparticles cause cell membrane
disintegration and increase cell surface permeability, inactivate
bacterial enzymes by interaction with thiol groups, deplete levels
of intracellular ATP, cause DNA damage and induce free radical
formation (Feng et al., 2000; Dibrov et al., 2002; Lok et al., 2006;
Li et al., 2010; Kim et al., 2011; Theophel et al., 2014).
Although silver nanoparticles show excellent antimicrobial
activity, silver-resistant bacteria have been described; and
these microorganisms can quickly develop resistance to silver
nanoparticles by genetic alterations (Losasso et al., 2014; Graves
et al., 2015).
The combination of several antimicrobials seems to be the
best strategy for controlling emergence of antibiotic-resistant
microorganisms (Fischbach, 2011; Bass et al., 2015; Bollenbach,
2015). Many studies show additive or synergistic antibacterial
effects of silver nanoparticles combined with alternative
(eugenol, phenazine-1-carboxamide, and cinnamaldehyde)
and conventional (ampicillin, kanamycin, erythromycin,
chloramphenicol, amoxicillin, ciprofloxacin, and moxifloxacin;
Li et al., 2005; Fayaz et al., 2010; Cardozo et al., 2013; Ghosh
et al., 2013; Theophel et al., 2014; Biasi-Garbin et al., 2015)
antimicrobial compounds. Synergistic and additive antimicrobial
effects have been reported for OEO or its components combined
with eugenol, linalool, menthol, cinnamaldehyde, Thymus
vulgaris essential oil, Rosmarinus officinalis essential oil,
gentamicin, polymyxin, kanamycin, levofloxacin or many others
(Rosato et al., 2007; Si et al., 2008; de Souza et al., 2009; Bassolé
and Juliani, 2012; Stojkovic´ et al., 2013; Honório et al., 2015).
Biological systems have been extensively used for rapid and
eco-friendly biosynthesis of silver nanoparticles; instead of using
chemical reagents, these processes involve fungi, bacteria, plants
and other organisms or biomolecules (Sastry et al., 2003; Durán
et al., 2005, 2011; Sankar et al., 2013; Singh et al., 2014). This
study evaluated, for the first time, the antibacterial effect of a
two-drug combination composed of bio-AgNP synthesized by
F. oxysporum and OEO against standard and resistant Gram-
positive and Gram-negative strains.
MATERIALS AND METHODS
Bacterial Strains
All antimicrobial assays were performed against reference strains
from American Type Culture Collection (ATCC) provided by
the Laboratory of Basic and Applied Bacteriology of Londrina
Stated University (Londrina, Paraná, Brazil), and clinical strains
provided from Londrina University Hospital (Londrina, Paraná,
Brazil). The standard bacterial strains used were as follows:
methicillin-sensitive S. aureus (ATCC 25923), Streptococcus
mutans (ATCC 25175), E. coli (ATCC 25922), K. pneumoniae
(ATCC 10031), K. pneumoniae (ATCC 700603), Salmonella
enterica serovar Enteritidis (ATCC 13076), S. enterica serovar
Typhimurium UK-1 (ATCC 68169) and MRSA N315 provided
by Dr. Elza Masae Mamizuka (São Paulo University, São Paulo
– SP, Brazil). Several clinical isolates obtained from Londrina
University Hospital were also tested (Table 1). Four isolates
of ESBL-producing E. coli and two isolates of carbapenemase-
producing E. coli from urinary tract infections (provided by
Dr. Eliana Carolina Vespero, Londrina University Hospital,
Londrina); one isolate of carbapenem-resistant A. baumannii
from inguinal-rectal swabs (provided by Dr. Floristher Elaine
Carrara Marroni, Londrina Clinics Hospital, Londrina) and two
isolates of MRSA strains from secretions-general discharges
(provided by Dr. Marcia Regina Eches Perugini, Londrina
University Hospital, Londrina). The bacterial strains were stored
in 25% glycerol (Merck) at−80◦C.
Antimicrobial Agents
Oregano Essential Oil
OEO was obtained from Ferquima Industry and Commerce
of Essential Oils (São Paulo, Brazil). This oil (batch 224) was
extracted by steam distillation and its density (0.954 g/mL)
and composition (main components: 71% carvacrol, 3% thymol,
4.5% gamma terpinene, 3.5% para-cymene, and 4% beta-
caryophyllene) were described in a technical report. A stock
solution of 50%OEOwas prepared in dimethylsulfoxide (DMSO,
Sigma-Aldrich; v/v). DMSO maximum concentration in assays
was 1%.
Silver Nanoparticles
Bio-AgNP were prepared according to a previously established
method (Durán et al., 2005, 2006). This method of production
has been patented (Patent, 2006, PI 0605681-4A2; http://www.
inpi.gov.br). Briefly, bio-AgNP were obtained after reduction
of silver nitrate by F. oxysporum, strain 551, from the culture
collection of the Molecular Genetics Laboratory of ESALQ-USP
(Piracicaba, São Paulo, Brazil). F. oxysporum was cultivated on
media containing 0.5% (w/v) yeast extract (Neogen), 2% (w/v)
malt extract (Neogen), 2% (w/v) agar (Neogen) and distilled
water at 28◦C for 7 days. After growth, the fungal biomass was
added to distilled water at 0.1 g/mL and incubated at 28◦C for
72 h. Afterwards, the solution components were separated by
filtration. AgNO3 (Nuclear) at 1 mM was added to fungal-free
solution, and the system was incubated for several hours at 28◦C
in the absence of light. Periodically, aliquots of the solution
system were removed and absorptions were measured using an
ultraviolet-visible spectrophotometry (Varian Cary 50 Probe); the
peak at 440 nm corresponded to the surface plasmon resonance
of silver nanoparticles. After bio-AgNP purification, diameter
was determined by photon correlation spectroscopy using
ZetaSizer NanoZS (Malvern), and zeta potential measurement
was performed using the same instrument.
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TABLE 1 | Susceptibility to antibiotics of clinical strains.
S. aureus PEN OXA CIP RIF GEN STR TET ERY CLI LNZ SXT
MRSA 101 R R R S S S S R R S S
MRSA 107 R R R S R R S R R S R
E. coli PTZ CEP CFZ CTX CAZ CPM AZT IPM MRP ERT NOR CIP LVX GEN AMI SXT NIT
ESBL 167 S – R R R R R S S S – R R S S R S
ESBL 169 S R – R R R R S S S R R S S S S S
ESBL 176 S R – R R R I S S S – S S S S S S
ESBL 192 S S – R R I S - S S – R R S S S S
KPC 131 R – – R S S R R R R – R – – S – –
KPC 133 I – – R I I R S R R – R – – S – –
A. baumannii PTZ AMS CTX CAZ CPM AZT IPM MRP ERT CIP LVX GEN AMI TET SXT
CR 01 R R R R R R R R R R R R R R R
AMI, amikacin; AMS, ampicillin+ sulbactam; AZT, aztreonam; CAZ, ceftazidime; CEP, cephalothin; CFZ, cefazolin; CIP, ciprofloxacin; CLI, clindamycin; CPM, cefepime; CTX, cefotaxime;
ERY, erythromycin; ETP, ertapenem; GEN, gentamicin; IPM, imipenem, LNZ, linezolid; LVX, levofloxacin; MRP, meropenem; NIT, nitrofurantoin; NOR, norfloxacin; OXA, oxacillin; PEN,
penicillin; PTZ, piperacillin + tazobactam; RIF, rifampin; STR, streptomycin; SXT, trimethoprim + sulfamethoxazole; TET, tetracycline.
R, resistant; S, susceptible; I, intermediate; (-), not tested.
MRSA, methicillin-resistant S. aureus.
ESBL, extended-spectrum beta-lactamases; KPC, K. pneumoniae carbapenemase; RC, carbapenem-resistant.
101, 107, 167, 169, 176,192, 131, 133, and 01 are strain numbers at Laboratory of Basic and Applied Bacteriology-Universidade Estadual de Londrina.
Antibacterial Activity of OEO and Bio-AgNP
Separately
MIC was determined by the broth dilution method according
to Clinical and Laboratory Standards Institute guidelines (CLSI,
2012), with necessary modifications. Tested concentrations of
OEO and bio-AgNP ranged from 0.075 to 9.540 mg/mL and
1.91 to 500 µM, respectively. Mueller-Hinton broth (MHB,
Difco) alone, MHB plus OEO and MHB plus bio-AgNP were
tested as sterility controls, and untreated bacteria inoculated
on MHB alone and with 1% DMSO were tested as growth
control. After 24 h incubation at 37◦C, MIC was defined as
the lowest concentration of antimicrobial agent that inhibited
visible growth. Minimal bactericidal concentration (MBC) was
determined by subculturing 10 µL from the broth dilution
MIC, after 24 h of treatment, in Mueller-Hinton agar (MHA,
Oxoid) with no antimicrobial agent. MBC was defined as the
lowest concentration that kills ≥99.9% of bacteria after 24 h of
antimicrobial treatment (NCCLS, 1999). All assays were carried
out in triplicate, and at least on three different occasions.
Antibacterial Combination Assay
Interaction of OEO and bio-AgNP was determined by broth
dilution in double-antimicrobial gradient as described by
Traub and Kleber (1975), with modifications. Single colonies of
bacterial cultures grown inMHAmedia were suspended in saline
solution (0.9% sodium chloride, w/v, Merck) and adjusted to 0.5
McFarland suspension which corresponds to 1 × 108 colony-
forming units/mL (CFU/mL). The inoculum at 1× 108 CFU/mL
was diluted 1:100 inMHB to yield 106 CFU/mL. A volume of 0.05
mL of bacterial inoculum at 106 CFU/mL was added to 0.05 mL
ofMHB complemented with combination of OEO and bio-AgNP
whose concentrations ranged from 0.037 to 0.596 mg/mL and
from 7.81 to 125 µM, respectively. Finally bacteria at 5 × 105
CFU/mL were grown in MHB with both antimicrobial agents
in combination at 37◦C for 24 h. Sterility and growth controls
were performed as in the MIC determination assay described
above. The interaction of both compounds was analyzed by
fractional inhibitory concentrations index (FICI) according Chin
et al. (1997), using the following equation: FICI = FICOEO +
FICbio-AgNP, where FIC = MICcombination/MICindividual. FICI is
interpreted as “synergistic” when ≤0.5, as “additive” when >0.5
and≤1, as “indifferent” (no interaction) when>1 and<4 and as
“antagonist” when ≥4. All assays were carried out in triplicate,
at least on three different occasions and against Gram-positive
and Gram-negative bacteria, including multidrug-resistant
strains.
Time-Kill Assay
Time-kill assay was carried out using the viable cells count
method, according to NCCLS (1999), with modifications. Three
conditions of treatments were tested, bacterial cultures treated
with OEO, bio-AgNP and their combination; and a bacterial
culture without antimicrobial agent served as growth control. At
ten time points (0 h, 30 s, 10 min, 20 min, 30 min, 2 h, 4 h,
7 h, 10 h, and 24 h) of incubation at 37◦C, 10 µL from serial
dilutions of treated and untreated cultures were transferred to
MHA and CFU/mL were determined. All assays were carried out
in triplicate, and at least on two different occasions, with three
bacterial strains (S. aureus ATCC 25923, E. coli ATCC 25922 and
carbapenemase-producing E. coli 131).
Scanning Electron Microscopy
S. aureus (ATCC 25923, non-MRSA) at 109 CFU/mL were
prepared in MHB and added to five tubes (5 mL of bacterial
inoculum each). S. aureus was exposed to three different
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treatments; OEO at 0.594 mg/mL was added to the first tube,
bio-AgNP at 250 µM were added to the second tube and the
two compounds combined were added to the third tube (OEO
at 0.297 mg/mL and bio-AgNP at 125 µM, 2x synergistic MIC
values to account for the increased cell density used for SEM
analyses). Incubation times at 37◦C varied for each treatment,
30 min for OEO and 6 h for bio-AgNP and combination of
antimicrobials. Two untreated controls were prepared, one with
30 min incubation and another with 6 h. After incubation, 20
µL of each sample were spotted onto poly-L-lysine (Sigma-
Aldrich)-coated glass slides. Each slide containing treated or
untreated bacteria was fixed (for 20 h) by immersion in 1
mL of 0.1 M sodium cacodylate buffer (pH 7.2) containing
2.5% glutaraldehyde and 2% paraformaldehyde. All samples
were then post-fixed in 1% osmium tetroxide for 2 h. All
reagents for both chemical fixations were provided from Electron
Microscopy Sciences. Post-fixed cells were dehydrated in an
ethanol gradient (Sigma-Aldrich) (70, 80, 90 and 100◦GL),
critical point-dried using CO2 (BALTEC CPD 030 Critical Point
Dryer), coated with gold (BALTEC SDC 050 Sputter Coater)
and observed under a scanning electron microscope (FEI Quanta
200).
Cytotoxicity Assay with Human Red Blood
Cells (RBC) and HEp-2cells
Hemolytic activity of OEO and bio-AgNP was determined
according to Izumi et al. (2012), with necessary modifications.
Blood was collected in heparinized tubes (Vacutainer) from
a healthy human donor with voluntary consent, which
was approved by the human ethics committee (CAAE
47661115.0.0000.5231, No. 1.268.019 – UEL). Erythrocytes
were separated by centrifugation (5000 rpm, 4◦C, 5 min) and
were prepared in phosphate-buffered saline (0.1 M PBS, pH 7.2)
at 6% (v/v). PBS was composed of 0.9% (w/v) sodium chloride
(Merck), 0.2 M monobasic sodium phosphate (Chemco) and 0.2
M dibasic sodium phosphate (Nuclear). In 96-well plates, 100
µL of RBC at 6% were added to 100 µL of PBS with different
concentrations of compounds individually and in combination.
After 3 h of incubation at 37◦C, supernatants were read at 550
nm to monitor release of hemoglobin. Triton X-100 (Sigma-
Aldrich) at 1% was used as control for 100% hemolytic activity,
and hemolysis percentage was calculated for each compound
concentration.
Cytotoxicity to the human laryngeal epithelial carcinoma cell
line HEp-2 was performed by the colorimetric dimethylthiazol
diphenyl tetrazolium bromide (MTT, Sigma-Aldrich) assay in 96-
well plates, according to the manufacturer’s recommendations.
HEp-2 cells were grown in RPMI medium 1640 (Gibco) at
37◦C in 5% CO2 to form a monolayer. Non-adherent cells were
removed using PBS and confluent cells were treated with different
concentrations of compounds individually and in combination
for 24 h at 37◦C in 5% CO2. After incubation, the medium was
removed and each well was washed with PBS. MTT solution (10
µL per well at 1.250 g/mL) was added to all wells, and plates were
incubated at 37◦C for 2 h. MTT solubilization solution (Sigma-
Aldrich) containing 10% Triton X-100 in acidic isopropanol (0.1
N HCl) was added to each well (90 µL per well) to dissolve the
dark blue crystals (formazan). After 15 min homogenization, the
plate was read at 570 nm. Untreated HEp-2 cells were used as
control for 100% viability, and viability percentage was calculated
for each compound concentration.
In both cytotoxicity assays, the concentrations of OEO
and bio-AgNP ranged 0.037–9.540 mg/mL and 1.95–250 µM,
respectively. The 50% cytotoxic concentration (CC50) was
defined as the antimicrobial concentration required to reduce cell
viability by 50% compared to untreated control. CC50 of each
compound was determined by regression analysis for both cell
lines, RBC and HEp-2 tumor cells.
Statistical Method
Results of MIC and time kill assay were analyzed using Wilcoxon
or Kruskal-Wallis test followed by Dunn’s test. Analyses were
performed using R Statistical Software, version 3.1.0 (Foundation
for Statistical Computing, Vienna, Austria). Values of p < 0.05
were considered significant.
RESULTS
Bio-AgNP Characterization
Average bio-AgNP size and zeta potential were 77.68 nm
and−34.6 mV, respectively (Supplementary Material).
MIC and Antimicrobial Interaction
OEO and bio-AgNP inhibited the growth of all bacterial strains
tested, including multidrug-resistant strains. The mean MIC for
OEO was 0.526± 0.130 mg/mL, and the meanMBC was 0.500±
0.158 mg/mL, MIC andMBC ranged from 0.298 to 1.193 mg/mL
(Table 2). The mean MIC for bio-AgNP was 129.17 ± 55.25 µM
ranging from 62.5 to 250µM, and the mean MBC was 154.17 ±
110.46 µM ranging from 62.5 µM to 500 µM (Table 2).
There was no statistical difference between standard and
multidrug-resistant strains with regard to MIC values of the
two individual compounds (p > 0.05). No significant difference
(p > 0.05) was observed between Gram-positive and Gram-
negative sensitivity to OEO, where both bacterial groups were
susceptible to this natural compound. Bio-AgNP showed better
activity against Gram-negative bacteria (p < 0.05), where the
mean MIC was 125 ± 56.53 µM in contrast to Gram-positive
mean MIC, which was 225± 55.90 µM.
In combination, OEO and bio-AgNP showed significantly
lowerMIC values when compared with individual treatment (p<
0.05), where the two compounds together resulted in synergistic
or additive antibacterial activity (Table 3).
Time-Kill Curve
OEO reduced the number of CFU/mL rapidly. For all three
strains tested (S. aureus ATCC 25923, E. coli ATCC 25922, KPC-
producing E. coli), after 10 min of treatment with OEO at MIC
(0.596mg/mL), there were no viable cells (p< 0.05; Figures 1–3).
The bacterial inhibition by OEO was immediate, where after 30 s
of treatment, there was a 0.57 log (p < 0.05), 1.54 log (p <
0.05), and 0.27 log (p< 0.05) reduction of S. aureus ATCC 25923
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TABLE 2 | Mean of minimal inhibitory and bactericidal concentrations of
oregano essential oil and biological silver nanoparticles.
Bacteria OEO (mg/mL) bio-AgNP (µM)
MIC MBC MIC MBC
S. aureus (ATCC 25923) 0.596 0.596 250.0 250.0
S. mutans (ATCC 25175) 0.596 0.596 125.0 250.0
E. coli (ATCC 25922) 0.596 0.596 62.50 62.50
S. enterica Enteritidis (ATCC 13076) 0.298 0.298 62.50 62.50
K. pneumoniae (ATCC 10031) 0.596 0.596 62.50 62.50
K. pneumoniae (ATCC 700603) 0.596 0.596 125.0 125.0
S. enterica Typhimurium UK-1* 0.298 0.298 125.0 125.0
MRSA N315 0.596 0.596 250.0 250.0
MRSA 101 1.193 1.193 250.0 500.0
MRSA 107 1.193 1.193 250.0 500.0
E. coli ESBL 167 0.596 0.596 125.0 125.0
E. coli ESBL 169 0.596 0.596 125.0 125.0
E. coli ESBL 176 0.596 0.596 125.0 125.0
E. coli ESBL 192 0.596 0.596 125.0 125.0
E. coli KPC 131 0.596 0.596 125.0 125.0
E. coli KPC 133 0.596 0.596 125.0 125.0
A. baumannii CR 01 0.298 0.298 125.0 125.0
OEO, oregano essential oil; bio-AgNP, biological silver nanoparticles.
MIC, minimal inhibitory concentration; MBC, minimal bactericidal concentration.
ATCC, American Type Culture Collection.
*, ATCC 68169.
MRSA, methicillin resistant S. aureus.
ESBL, extended spectrum beta-lactamase; KPC, K. pneumoniae carbapenemase.
CR, Carbapenem-resistant;
101, 107, 167, 169, 176,192, 131, 133, and 01 are strain numbers at Laboratory of Basic
and Applied Bacteriology-Universidade Estadual de Londrina.
(Figure 1), E. coli ATCC 25922 (Figure 2), and carbapenemase-
producing E. coli (Figure 3) cell populations, respectively.
Bio-AgNP at MIC (250 µM) showed bactericidal effect at 24 h
to S. aureus ATCC 25923 (p < 0.05; Figure 1). After 10 h of
treatment, the S. aureus cell population decreased by 0.57 log (p<
0.05); and between 10 and 24 h of treatment, there was a 4.73 log
reduction (p < 0.05). Gram-negative bacteria lost total viability
after 4 h of incubation with bio-AgNP at 62.5 and 125 µM for
E. coli ATCC 25922 (Figure 2) and carbapenemase-producing E.
coli (Figure 3), respectively (p < 0.05). In both Gram-negative
bacteria, after 2 h of exposure to bio-AgNP, there was a significant
decrease in CFU/mL, 3.3 and 2.31 log reduction in standard E.
coli (Figure 2) andKPC-producing E. coli (Figure 3), respectively
(p< 0.05).
The combination of OEO and bio-AgNP led to faster
reduction of CFU/mL than in individual treatment with bio-
AgNP. Against S. aureus ATCC 25923, the combination of the
two compounds at synergistic MIC (0.149 mg/mL and 62.5
µM for OEO and bio-AgNP, respectively) showed bacteriostatic
activity (data not shown). But the combination with additiveMIC
values (0.298 mg/mL OEO and 125 µM bio-AgNP) against S.
aureus ATCC 25923 caused a 3.48 log decrease in cell population
in 2 h (p < 0.05) and resulted in no viable bacterial cells at 7 h (p
< 0.05; Figure 1).
TABLE 3 | Combinatory effect of oregano essential oil and biological silver
nanoparticles and both minimal inhibitory concentrations in combination.
MIC FICI
Bacteria OEO (mg/mL) Bio-AgNP (µM)
S. aureus (ATCC 25923) 0.149 62.50 0.50 (S)
S. mutans (ATCC 25175) 0.075 62.50 0.62 (A)
E. coli (ATCC 25922) 0.298 15.62 0.75 (A)
S. enterica Enteritidis (ATCC 13076) 0.037 31.25 0.62 (A)
K. pneumoniae (ATCC 10031) 0.075 15.62 0.37 (S)
K. pneumoniae (ATCC 700603) 0.075 62.50 0.62 (A)
S. enterica Typhimurium UK-1* 0.149 62.50 1.00 (A)
MRSA N315 0.075 125.0 0.62 (A)
MRSA 101 0.596 62.50 0.75 (A)
MRSA 107 0.596 62.50 0.75 (A)
E. coli ESBL 167 0.149 15.62 0.37 (S)
E. coli ESBL 169 0.149 15.62 0.37 (S)
E. coli ESBL 176 0.149 31.25 0.50 (S)
E. coli ESBL 192 0.149 31.25 0.50 (S)
E. coli KPC 131 0.075 31.25 0.37 (S)
E. coli KPC 133 0.075 62.50 0.62 (A)
A. baumannii CR 01 0.149 15.62 0.62 (A)
OEO, oregano essential oil; bio-AgNP, biological silver nanoparticles.
ATCC, American Type Culture Collection.
*, S. enterica Typhimurium ATCC 68169.
MRSA, methicillin resistant S. aureus.
ESBL, extended spectrum beta-lactamase; KPC, K. pneumoniae carbapenemase.
CR, Carbapenem-resistant.
101, 107, 167, 169, 176,192, 131, 133 and 01 are strain numbers at Laboratory of Basic
and Applied Bacteriology-Universidade Estadual de Londrina.
FICI, fractional inhibitory concentration index.
FIC index were interpreted as follows: ≤ 0.5, synergy; > 0.5 to 1.0, addition; > 1.0 to <
4.0, indifference; and ≥ 4, antagonism.
(S), Synergistic interaction; (A), Additive interaction.
Against standard E. coli (ATCC 25922), OEO and bio-AgNP at
additive MIC (0.298 mg/mL and 15.62 µM, respectively) caused
a 2.3 log decrease (p < 0.05) within 10 min of treatment and
there were no viable cells after 20 min (p< 0.05; Figure 2). At 30
min of incubation with synergistic MIC values (0.075mg/mL and
31.25 µM for OEO and bio-AgNP, respectively), the population
of carbapenemase-producing E. coli decreased 2.7 log (p < 0.05)
and after 2 h there was a total reduction of bacterial population
(p< 0.05; Figure 3).
Scanning Electron Microscopy
To investigate antimicrobial activity against S. aureus ATCC
25923 (non-MRSA) by OEO, bio-AgNP and combination of
the two treatment, the morphology changes were investigated
with SEM. Untreated cells showed their unique shapes (spherical
shaped) 30min (Figure 4A) and 6 h (Figure 4B) after incubation.
Inset images showed, seen clearly in the higher magnification,
intact surface of S. aureus ATCC 25923 (Figures 4A,B - inset).
Although cells treated after 30 min with OEO alone was still
present, most of themwere damaged and extensively disappeared
(Figure 4C). Inset showed details, in higher magnification, of
morphological changes on the cells surface (Figure 4C - inset).
Treatment with bio-AgNP alone after 6 h showed a decrease
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FIGURE 1 | Time-kill curves of S. aureus 25923 (ATCC) exposed to OEO
and bio-AgNP individually and in combination at MIC values. Bacteria at
5 × 105 CFU/mL were exposed to three different treatments; OEO alone
(0.596 mg/mL), bio-AgNP alone (250µM), and OEO + bio-AgNP (0.298
mg/mL + 125 µM). Control indicates bacterial growth without antimicrobial
compounds. Values of CFU/mL are the mean ± standard deviation.
FIGURE 2 | Time-kill curves of E. coli 25922 (ATCC) exposed to OEO
and bio-AgNP individually and in combination at MIC values. Bacteria at
5 × 105 CFU/mL were exposed to three different treatments; OEO alone
(0.596 mg/mL), bio-AgNP alone (62.5 µM) and OEO + bio-AgNP (0.298
mg/mL + 15.62 µM). Control indicates bacterial growth without antimicrobial
compounds. Values of CFU/mL are the mean ± standard deviation.
in cell density and caused morphological changes (Figure 4D).
Inset show, in the higher magnification, cells walls covered
with substance resulting from serious disruptions in the surface
FIGURE 3 | Time-kill curves of carbapenemase-producing E. coli
exposed to OEO and bio-AgNP individually and in combination at MIC
values. Bacteria at 5 × 105 CFU/mL were exposed to three different
treatments; OEO alone (0.596 mg/mL), bio-AgNP alone (125 µM), and OEO +
bio-AgNP (0.075 mg/mL + 31.25 µM). Control indicates bacterial growth
without antimicrobial compounds. Values of CFU/mL are the mean ± standard
deviation.
of S. aureus ATCC 25923 (Figure 4D - inset). Cells treated
with combination of OEO plus bio-AgNP (Figure 4E) showed
very deformed cells, with cell debris and damages appeared as
cell surface blebbing after 6 h treatment (Figure 4E - inset).
Treatments with OEO plus bio-AgNP showed a decrease in
cell density, exopolysaccharide, morphology changes, and cell
destruction, compared to the non-treated cells. It indicated that
this composition have an antimicrobial activity against S. aureus
by disrupting cells.
Cytotoxicity Assay in Human RBC and
HEp-2 cells
Results of MTT assay showed that OEO was toxic to tumor
cells (HEp-2 cells), reducing cell metabolism by 50% or more
at concentrations higher than 0.075 mg/mL (Figure 5A). But
this essential oil was less toxic to RBC, and the CC50 was
7.519 mg/mL (Figure 6A). CC50 of bio-AgNP in HEp-2 cells
was 97.22 µM (Figure 5B), and very low hemolytic activity was
observed even at the highest concentration tested (250 µM;
Figure 6B).
The compounds in combination were non-toxic to HEp-
2 cells at concentrations of 0.075 mg/mL and 31.25 µM
to OEO and bio-AgNP respectively, or at lower values
concentrations. The combination of 0.075 mg/mL of OEO
and 125 µM or 62.5 µM of bio-AgNP showed toxicity to
HEp-2 cells (Table 4). However, the combination of OEO and
bio-AgNP was non-toxic to RBC at all concentrations tested
(Table 5).
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FIGURE 4 | Scanning electron micrograph of antibacterial effect of
OEO and bio-AgNP alone and in combination against S. aureus ATCC
25923 (non-MRSA). (A) Untreated control after 30 min incubation. (B)
Untreated control after 6 h incubation. (C) Treated cells with OEO at 0.596
mg/mL for 30 min. (D) Treated cells with bio-AgNP at 250 µM for 6 h. (E)
Treated cells with combination of OEO and bio-AgNP at 0.298 mg/mL and
125 µM, respectively, for 6 h. Micrographs (A–E) show cell density and
exopolysaccharide matrix (15,000 x). Inset images show detail of
morphological alterations of treated cells and typical cell morphology of
untreated controls (30,000 x). Arrows: morphological changes (surface
protrusions) and cellular debris. Arrowheads: exopolysaccharide.
DISCUSSION
This study showed that OEO has potent bactericidal activity
at low concentration with fast action, in agreement with
previous studies (Burt and Reinders, 2003; Souza et al., 2010;
Betancourt et al., 2012; Alvarez et al., 2014). Busatta et al.
(2007) reported for OEO MIC values of 0.23 and 0.46 mg/mL
against methicillin-sensitive S. aureus and E. coli ATCC 25922
respectively. Betancourt et al. (2012) found for OEO a MIC
of 0.780 mg/mL against S. enterica and 3.125 mg/mL against
E. coli. OEO MIC values obtained in our study ranged from
0.298 to 1.193 mg/mL (Table 2), which were in line with
literature results. Our analysis showed that OEO at a low
concentration was bactericidal against all multidrug-resistant
bacteria tested, with MBC values of 0.298 mg/mL against
A. baumannii, 0.596 mg/mL against ESBL and KPC-producing
E. coli isolates and 1.193 mg/mL against both clinical MRSA
isolates.
FIGURE 5 | HEp-2 cell viability at different concentrations of OEO and
bio-AgNP individually. (A) HEp-2 cell exposed to OEO alone ranging from
0.075 to 9.540 mg/mL. (B) HEp-2 cell exposed to bio-AgNP alone ranging
from 1.95 to 250 µM. Percentage values of cell viability are the mean ±
standard deviation.
Time-kill assays showed that OEO reduced cell populations
nearly 5 log (after 10 min of treatment) in all three bacterial
strains tested (p < 0.05), so our results indicated that OEO acted
within a few minutes against S. aureus ATCC 25923 (Figure 1),
E. coli ATCC 25922 (Figure 2), and KPC-producing E. coli
(Figure 3). Burt and Reinders (2003) showed that when E. coli
O157:H7 at 5× 105 CFU/mL were exposed to OEO (0.06%, v/v),
there were no viable cells after 1 min of treatment. In a study
with S. aureus isolated from food, Barros et al. (2009) found
that OEO at MIC (0.06%, v/v) caused 3 log reduction of initial
inoculum (108 CFU/mL) after 2 h of treatment. In our study
using an equal initial inoculum (S. aureus at 108 CFU/mL) and
same OEO concentration (0.596 mg/mL; corresponding to 0.06
%, v/v), there were no viable cells after 30 min (p < 0.05), due to
a 8 log reduction of S. aureus ATCC 25923 population (data not
shown).
Some studies have found that terpenoid compounds
from OEO are more active against Gram-positive bacteria
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FIGURE 6 | Hemolytic activity of different concentrations of OEO and
bio-AgNP individually. (A) Human erythrocytes exposed to OEO alone
ranging from 0.075 to 9.540 mg/mL. (B) Human erythrocytes exposed to
bio-AgNP ranging from 1.95 to 250 µM. Values of hemolysis percentage are
the mean ± standard deviation.
(Smith-Palmer et al., 1998; Lambert et al., 2001; Stojkovic´
et al., 2013). Our results indicated that OEO has broad-
spectrum action in agreement with previous studies (Busatta
et al., 2007; Rosato et al., 2010; Stojkovic´ et al., 2013; Alvarez
et al., 2014), where it was equally effective according to
MIC (Table 2) and time of action (Figures 1–3) against
Gram-positive and Gram-negative bacteria (p > 0.05); these
results are in line with those obtained by other researchers
(Dorman and Deans, 2000; Rosato et al., 2010). This variable
susceptibility of bacteria to essential oils can be due to
the chemical composition of essential oils, which varies
according to seasonal and geographical factors (Medini et al.,
2009).
TABLE 4 | HEp-2 cell viability at different concentrations of oregano
essential oil (OEO) and biological silver nanoparticles (bio-AgNP) in
combination.
Combination Tested concentrations Viable cells (%)
OEO (mg/mL) bio-AgNP (µM)
A1 0.596 125.0 0.95±0.69
A2 0.596 62.50 1.36±0.59
A3 0.596 31.25 0.99±0.15
A4 0.596 15.62 1.27±0.40
B1 0.298 125.0 1.18±0.20
B2 0.298 62.50 1.72±0.57
B3 0.298 31.25 1.04±0.20
B4 0.298 15.62 1.99±4.64
C1 0.149 125.0 7.80±2.00
C2 0.149 62.50 21.81±12.19
C3 0.149 31.25 22.94±14.00
C4 0.149 15.62 72.01±17.60NC
D1 0.075 125.0 38.68±8.49
D2 0.075 62.50 51.61±3.25
D3 0.075 31.25 94.24±3.67NC
D4 0.075 15.62 100±0.00NC
E1 0.037 125.0 61.54±6.92NC
E2 0.037 62.50 82.27±10.55NC
E3 0.037 31.25 100±0.00NC
E4 0.037 15.62 100±0.00NC
Concentrations of OEO (mg/mL) in combination: A, 0.596; B, 0.298; C, 0.149; D, 0.075;
E, 0.037.
Concentrations of bio-AgNP (µM) in combination: (1) 125; (2) 62.5; (3) 31.25; (4) 15.62.
NC, non-cytotoxic, ±, standard deviation.
Many studies suggest that essential oils affect the bacterial cell
membrane resulting in growth inhibition, since this structure
supports the most essential functions in prokaryotes. Bennis
et al. (2004) reported cell surface changes such as curling
and cracks in Saccharomyces cerevisiae treated with thymol.
Lambert et al. (2001) suggested that OEO inhibits bacterial
growth due to damage to membrane integrity, affecting pH
homeostasis and equilibrium of inorganic ions. Suzuki et al.
(2015) found physical damage and morphological alterations in
Staphylococcus epidermidis treated with OEO products. Souza
et al. (2010) showed loss of 260 nm-absorbing material and
release of potassium ions of S. aureus cells treated with
OEO, results suggesting increased membrane permeability. In
our study, SEM observations confirmed physical damage and
considerable morphological alteration as cell surface blebbing in
S. aureus ATCC 25923 (non-MRSA) cells exposed to OEO for
30 min (Figure 4C), compared to control (untreated bacteria)
showing no morphological changes after 30 min (Figure 4A).
This analysis by electron microscopy revealed a decrease in
cell density of OEO-treated bacteria sample when compared to
control sample, according with time kill results at 30 min of
incubation (data not shown).
In our RBC toxicity assay, OEO CC50 was 7.519 mg/mL
(Figure 6A). OEO did not appear to be toxic to RBC, since MIC
values ranged from 0.037 mg/mL to 1.193 mg/mL (Tables 2, 3).
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TABLE 5 | Hemolytic activity of oregano essential oil (OEO) and biological
silver nanoparticles (bio-AgNP) in combination.
Combination Tested concentrations Hemolysis (%)
OEO (mg/mL) bio-AgNP (µM)
A1 0.596 125.0 6.49 ± 2.29NC
A2 0.596 62.50 2.86 ± 0.11NC
A3 0.596 31.25 1.95 ± 0.11NC
A4 0.596 15.62 0.49 ± 0.13NC
B1 0.298 125.0 7.56 ± 1.16NC
B2 0.298 62.50 2.60 ± 1.33NC
B3 0.298 31.25 0.77 ± 0.37NC
B4 0.298 15.62 0.19 ± 0.32NC
C1 0.149 125.0 8.44 ± 0.98NC
C2 0.149 62.50 4.58 ± 0.23NC
C3 0.149 31.25 0.19 ± 0.17NC
C4 0.149 15.62 1.26 ± 0.19NC
D1 0.075 125.0 7.75 ± 0.93NC
D2 0.075 62.50 2.67 ± 0.73NC
D3 0.075 31.25 0.42 ± 0.13NC
D4 0.075 15.62 0.00 ± 0.00NC
E1 0.037 125.0 5.81 ± 2.27NC
E2 0.037 62.50 1.57 ± 0.27NC
E3 0.037 31.25 0.42 ± 0.53NC
E4 0.037 15.62 0.00 ± 0.00NC
Concentrations of OEO (mg/mL) in combination: A, 0.596; B, 0.298; C, 0.149; D, 0.075;
E, 0.037.
Concentrations of bio-AgNP (µM) in combination: (1) 125; (2) 62.5; (3) 31.25; (4) 15.62.
NC, non-cytotoxic, ±, standard deviation.
The lack of cytotoxicity of OEO to erythrocytes has also been
found by other investigators. Mancini et al. (2014) reported
no hemolytic activity of OEO against bovine erythrocytes, and
Cacciatore et al. (2015) showed that carvacrol derivatives did
not produce human blood hemolysis at their MIC values. OEO
was toxic to HEp-2 cells (Figure 5A), and there are previous
studies using tumor cells, including HEp-2 cells, that reported the
antitumor activity of OEO or its components (Mehdi et al., 2011;
Gautam et al., 2014; Sobral et al., 2014).
Due to its strong antimicrobial property, OEO has potential to
replace antibiotics in the food industry and can be incorporated
in cosmetic products, among other applications (Alvarez
et al., 2014; Suzuki et al., 2015). However, the high volatile
character and undesirable organoleptic features can limit its use;
therefore, alternatives to solve these limitations are required
(Burt, 2004; Alvarez et al., 2014; Hernández-Hernández et al.,
2014).
In this study, bio-AgNP exhibited broad-spectrum
antibacterial action, inhibiting growth of both Gram-positive and
-negative bacteria, in agreement with the literature (Busatta et al.,
2007; Jain et al., 2009; Kim et al., 2011). The mean MIC value
obtained in our study (129 µM) was according with previous
studies using silver nanoparticles produced by F. oxysporum
that reported MIC value of 125 µM (Cardozo et al., 2013;
Biasi-Garbin et al., 2015). However, we found that Gram-positive
bacteria were more tolerant to silver nanoparticles because
bio-AgNP MIC values were higher (Table 2) and time of action
was slower, compared to Gram-negative bacteria (Figures 1–3),
as reported in other studies (Jain et al., 2009; Durán et al., 2010;
Agnihotri et al., 2014). Kim et al. (2011) showed that Gram-
negative bacteria were more susceptible to silver nanoparticles
compared to Gram-positive strains, where there was increased
bactericidal activity in time kill assay, loss of protein through
the membrane and inactivation of lactate dehydrogenase (LDH),
besides marked morphological changes.
The size of the nanoparticles is a key point in their
antibacterial activity, where many studies show that antibacterial
activity is particle size dependent; antimicrobial activity of
nanoparticles increases with smaller size (Panacek et al., 2006;
Ayala-Núñez et al., 2009; Agnihotri et al., 2014), and this fact
accounts for the variation in MIC data between different studies,
limiting comparison.
Our analysis by SEM showed surface protrusions on bio-
AgNP treated S. aureus cells (non-MRSA) (Figure 4D). Kim
et al. (2011) reported that bacterial cells treated with silver
nanoparticles had irregular fragments on the surface, a large
protein leakage and decrease in bacterial growth; suggesting that
fragments can be lost cytoplasmic material resulting in damage
to the membrane with a consequent increase in permeability.
Studies also report that silver ions have an affinity for thiol groups
and may damage respiratory enzymes of cytoplasmic membrane
(Holt and Bard, 2005; Li et al., 2010).
In our RBC toxicity assay, bio-AgNP were not cytotoxic
to human blood cells (Figure 6B). Our metal compound did
not exhibit cytotoxic effect on RBC at the concentrations
studied, 250 µM (37.5 µg/mL) to 1.95 µM (0.29 µg/mL), so
it was not possible to calculate CC50 for human erythrocytes.
Spectrophotometric analysis of supernatants indicated that bio-
AgNP did not increase absorbance, demonstrating that little
hemoglobin was released from the RBC. Choi et al. (2011)
showed that the silver nanoparticles at 700 µg/mL lysed 50%
of RBC. According to ASTM E2524-08 (2013)1 standards,
hemolysis > 5% indicates damage to RBC; in our study, the
highest bio-AgNP concentration tested (250 µM) showed only
1.4% hemolysis. Our MTT assay results showed that bio-
AgNP was toxic to HEp-2 cells only at high concentrations
(CC50 = 97.22 µM), often above that needed to inhibit bacterial
growth. Some authors have reported antitumor activity of silver
nanoparticles, supporting our finding of bio-AgNP being more
toxic to HEp-2 cells than to RBC (Devi and Bhimba, 2012;
Antony et al., 2013).
Despite the effective antimicrobial action of bio-AgNP with
broad spectrum activity and low cytotoxicity, bacteria can easily
develop resistance to these nanoparticles by simple genetic
changes (Graves et al., 2015). Thus, alternative studies to work
around this problem are needed.
Combined drug treatment is recommended as a strategy to
control antimicrobial resistance (Fischbach, 2011; Bollenbach,
2015). Li et al. (2005) observed a synergistic effect of silver
1ASTM E2524-08 (2013). Standard Test Method for Analysis of Hemolytic
Properties of Nanoparticles. Available online at: http://www.astm.org/Standards/
E2524.htm [Accessed October 17, 2015].
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nanoparticles combined with amoxicillin against E. coli, and
other studies have shown a synergistic interaction with other
natural alternative compounds such as cinnamaldehyde (Ghosh
et al., 2013), eugenol (Biasi-Garbin et al., 2015), and phenazine-
1-carboxamide (Cardozo et al., 2013).
Other studies have shown that the OEO acts in synergismwith
some conventional antimicrobials such as gentamicin against
S. aureus 29213, E. coli 25922, and A. baumannii 19606 (Rosato
et al., 2010), or has an additive effect in combination with
amoxicillin, polymyxin, and lincomycin against ESBL-producing
E. coli (Si et al., 2008). OEO shows synergistic effects with
natural substances such as essential oil of Thymus vulgare and
Rosmarinus officinalis (Stojkovic´ et al., 2013; Honório et al.,
2015).
In the literature, OEO (Nostro et al., 2004; Si et al.,
2008; Amrouni et al., 2014) and silver nanoparticles (Cardozo
et al., 2013; Singh et al., 2014; Subashini et al., 2014)
were shown to be active against multidrug-resistant bacteria.
But this study showed, for the first time, synergistic and
additive effects of a combination of OEO and bio-AgNP
against bacterial strains, including MRSA and beta-lactamase-
or carbapenemase-producing bacteria. Synergistic and additive
drug interactions may be potential strategies for controlling
resistance evolution, since administration of multiple drugs may
disrupt several bacterial functions and thus minimize selection
of resistant strains (Yeh et al., 2009; Bollenbach, 2015). In
combination, both compounds were effective at concentrations
that individually do not affect human erythrocyte (Figure 5),
and their synergistic or additive effects neither impact such
cells (Table 5). However, OEO combined with bio-AgNP was
cytotoxic to HEp-2 (Table 4); as observed for these compounds
individually. The combination also showed antibacterial activity
in short time (Figures 1–3). Furthermore, the undesirable
organoleptic characteristics of OEO are decreased, since the
synergistic or additive interaction reduces the concentration of
both compounds.
Our results highlight the powerful action of OEO combined
with bio-AgNP against Gram-negative bacteria, including
those producing ESBL and carbapenemases (Table 3,
Figures 2, 3). The combination of the two substances also
showed activity against Gram-positive bacteria, since the FICI
indicated synergistic and additive interactions (Table 3),
and SEM confirmed this antimicrobial action through
changes in the S. aureus (non-MRSA) cell surface and
decrease in cell density (Figure 4E) compared to control
(Figure 4B).
In conclusion, the combination of bio-AgNP with OEO
resulted in synergistic and additive antimicrobial activities
against the multidrug-resistant bacterial strains of E. coli,
A. baumannii and MRSA. Therefore bio-AgNP combined with
OEO has potential to be applied in industry (cosmetics, food and
pharmaceutical, for example) and clinical and hospital settings
(i.e., for treating wounds and burns infections, or for disinfecting
hospital to combat resistant strains as A. baumannii).
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